Age associated high level of major vault protein is p53 dependent

Cell Biochemistry and Function

Volumn 27, Issue 5, 2009, Pages 289-295

  An, Hong Joo ^a   Ryu, Sung Jin ^a   Kim, Sung Young ^a   Choi, Hai Ri ^a   Chung, Jun Ho ^a   Park, Sang Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Fibroblast; MVP; p53; Senescence; Transcription factor

Indexed keywords

HYDROGEN PEROXIDE; LUNG RESISTANCE PROTEIN; PROTEIN P53; SMALL INTERFERING RNA; RIBONUCLEOPROTEIN;

AGE; ARTICLE; CHILD; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIPLOIDY; DOWN REGULATION; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SENESCENCE; TRANSCRIPTION REGULATION; UPREGULATION; APOPTOSIS; CELL AGING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

APOPTOSIS; CELL AGING; DIPLOIDY; FIBROBLASTS; HUMANS; HYDROGEN PEROXIDE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 70349229941     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1571     Document Type: Article

References (34)

1. Mossink M, van Zon A, Franzel-Luiten E, et al. The genomic sequence of the murine major vault protein and its promoter. Gene 2002; 294(1-2): 225-232.
2. Zheng CL, Sumizawa T, Che XF, et al. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. Biochem Biophys Res Commun 2005; 326(1): 100-107.
3. van Zon A, Mossink MH, Scheper RJ, et al. The vault complex. Cell Mol Life Sci 2003; 60(9): 1828-1837.
4. van Zon A, Mossink MH, Houtsmuller AB, et al. Vault mobility depends in part on microtubules and vaults can be recruited to the nuclear envelope. Exp Cell Res 2006; 312(3): 245-255.
5. Kickhoefer VA, Rajavel KS, Scheffer GL, et al. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem 1998; 273(15): 8971-8974.
6. Schroeijers AB, Reurs AW, Scheffer GL, et al. Up-regulation of drug resistance-related vaults during dendritic cell development. J Immunol 2002; 168(4): 1572-1578.
7. Kowalski MP, Dubouix-Bourandy A, Bajmoczi M, et al. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 2007; 317(5834): 130-132.
8. Mrazek J, Kreutmayer SB, Grasser FA, et al. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 2007; 35(10): e73.
9. Kolli S, Zito CI, Mossink MH, Wiemer EA, Bennett AM. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem 2004; 279(28): 29374-29385.
10. Yu Z, Fotouhi-Ardakani N, Wu L, et al. PTEN associates with the vault particles in HeLa cells. J Biol Chem 2002; 277(43): 40247-40252.
11. Kim E, Lee S, Mian MF, et al. Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling. FEBS J 2006; 273(4): 793-804.
12. Vasu SK, Rome LH. Dictyostelium vaults: disruption of the major proteins reveals growth and morphological defects and uncovers a new associated protein. J Biol Chem 1995; 270(28): 16588-16594.
13. Komarov PG, Shtil AA, Holian O, et al. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. Oncol Res 1998; 10(4): 185-192.
14. Stein U, Walther W, Laurencot CM, et al. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. J Natl Cancer Inst 1997; 89(11): 807-813.
15. Lange C, Walther W, Schwabe H, Stein U. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. Biochem Biophys Res Commun 2000; 278(1): 125-133.
16. Steiner E, Holzmann K, Pirker C, et al. SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. Biochem Biophys Res Commun 2004; 317(1): 235-243.
17. Stein U, Bergmann S, Scheffer GL, et al. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene. Oncogene 2005; 24(22): 3606-3618.
18. Steiner E, Holzmann K, Pirker C, et al. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. J Cell Sci 2006; 119 (Pt 3): 459-469.
19. Ryu SJ, An HJ, Oh YS, et al. On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis. Cell Death Differ 2008; 14(5): 1020-1028.
20. Ryu SJ, Cho KA, Oh YS, Park SC. Role of Src-specific phosphorylation site on focal adhesion kinase for senescence-associated apoptosis resistance. Apoptosis 2006; 11(3): 303-313.
21. Ryu SJ, Oh YS, Park SC. Failure of stress-induced downregulation of Bcl-2 contributes to apoptosis resistance in senescent human diploid fibroblasts. Cell Death Differ 2007; 14(5): 1020-1028.
22. Berger W, Elbling L, Micksche M. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Int J Cancer 2000; 88(2): 293-300.
23. Steiner E, Holzmann K, Elbling L, et al. Cellular functions of vaults and their involvement in multidrug resistance. Curr Drug Targets 2006; 7(8): 923-934.
24. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408(6810): 307-310.
25. el-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol 1998; 8(5): 345-357.
26. el-Deiry WS, Kern SE, Pietenpol JA, et al. Definition of a consensus binding site for p53. Nat Genet 1992; 1(1): 45-49.
27. Goldfarb T, Alani E. Chromatin immunoprecipitation to investigate protein-DNA interactions during genetic recombination. Methods Mol Biol 2004; 262: 223-237.
28. Slee EA, O'Connor DJ, Lu X. To die or not to die: how does p53 decide? Oncogene 2004; 23(16): 2809-2818.
29. Bailey SL, Gurley KE, Hoon-Kim K, et al. Tumor suppression by p53 in the absence of Atm. Mol Cancer Res 2008; 6(7): 1185-1192.
30. Ventura A, Kirsch DG, McLaughlin ME, et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445(7128): 661-665.
31. Deb SP, Munoz RM, Brown DR, et al. Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 1994; 9(5): 1341-1349.
32. Warnick CT, Dabbas B, Ford CD, Strait KA. Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells. J Biol Chem 2001; 276(29): 27363-27370.
33. Yoon KA, Nakamura Y, Arakawa H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 2004; 49(3): 134-140.
34. Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126(1): 107-120.